Jinhai Medical Technology (HKSE:02225) Risk Assessment

View and export this data going back to 2017. Start your Free Trial

What is Jinhai Medical Technology Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Jinhai Medical Technology is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Jinhai Medical Technology's Risk Assessment

For the Staffing & Employment Services subindustry, Jinhai Medical Technology's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jinhai Medical Technology's Risk Assessment Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Jinhai Medical Technology's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Jinhai Medical Technology's Risk Assessment falls into.

Jinhai Medical Technology (HKSE:02225) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Jinhai Medical Technology Risk Assessment Related Terms

Thank you for viewing the detailed overview of Jinhai Medical Technology's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinhai Medical Technology (HKSE:02225) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Jinhai Medical Technology Ltd (HKSE:02225) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

31 Sungei Kadut Avenue, Singapore, SGP, 729660

Website

https://www.jin-hai.com.hk

Jinhai International Group Holdings Ltd is a Singapore-based company engaged in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. It also provides dormitory services, IT services, and construction ancillary services including warehousing services, cleaning services, and building maintenance work in Singapore. It earns a vast majority of its revenues from the Manpower outsourcing and ancillary services segment.

Executives

Liu Lei	2101 Beneficial owner
Chen Guobao	2201 Interest of corporation controlled by you
Full Fortune International Co., Ltd.	2101 Beneficial owner
Jiang Xiahong	2202 Interest of your spouse

Jinhai Medical Technology (HKSE:02225) Headlines

No Headlines